Yeming Wu

机构：Shanghai Jiao Tong University, XinHua Hospital, Tongren Hospital · ORCID：0000-0003-3559-4817

发表论文 47 篇 · 总被引 1437 次 · h-index 16

代表论文

• The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation (2018 · Journal of Experimental & Clinical Cancer Research · 被引 61)
• The deubiquitinating enzyme UCHL1 negatively regulates the immunosuppressive capacity and survival of multipotent mesenchymal stromal cells (2018 · Cell Death and Disease · 被引 56)
• PCLAF promotes neuroblastoma G1/S cell cycle progression via the E2F1/PTTG1 axis (2022 · Cell Death and Disease · 被引 53)
• XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor (2021 · Journal of Experimental & Clinical Cancer Research · 被引 30)
• Bufalin exerts antitumor effects in neuroblastoma via the induction of reactive oxygen species‑mediated apoptosis by targeting the electron transport chain (2020 · International Journal of Molecular Medicine · 被引 24)
• MYT1 attenuates neuroblastoma cell differentiation by interacting with the LSD1/CoREST complex (2020 · Oncogene · 被引 22)